Aizon Secures $20M in Series C Funding Led by NewVale Capital to Enhance Pharma Manufacturing Outcomes
Investment underscores Aizon’s leadership position in AI-enhanced pharmaceutical manufacturing and will accelerate growth and launch of next-generation eBR February 08, 2024 09:55 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Aizon, an Artificial Intelligence (AI) SaaS provider…